No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
GlycoMimetics | 10-Q: Q3 2024 Earnings Report
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
Express News | Adage Capital Management LP Reports 7.9% Stake in GlycoMimetics Inc as of Oct 29 - SEC Filing
M&A Deals Roundup: AbbVie, Blackstone, Take-Two Interactive and More
GlycoMimetics Announces Merger With Crescent Biopharma